Zusammenfassung der Ressource
Pharmacology
Anmerkungen:
- Can be split into two groups: PHARMOKINETICS
PHARMOCODYNAMICS
- PHARMOKINETICS
- The movement of drugs through the body
- 4 stages
- Absorption
- Heavily influenced by route of administration
- ENTERAL
- VIA gastro-intestinal tract
- Tablets, oral liquids
- Travel through GI tract
- Absorbed in small intestine
- Stomach tubing
- Absorbed across intestinal wall- enters hepatic portal
- Blood vessel that conducts blood from GI to liver
- First pass effect: METABOLISM
- PARTIALLY broken down by liver, excreted into bile, back into GI tract
- Parenteral
- Other than gastro-intestinal
- Injections
- Topical
- Tissue perfusion
- Affects rate of absorption
- Vasoconstriction: decrease blood flow, decreased absorption
- Vasodilation- increased blood flow, increased absorption
- Distribution
- where the drug can get to- often limited by chemical properties
- Movement through body fluids and tissues
- Blood=WATER= mainly hydrophilic molecules can dissolve and be carried by the blood
- Cell membranes=fat= lipophilc substances enter cells easier
- Metabolism
- what the body chemically does to the drug- denatured, activated- LIVER
- BIOTRANSFORMATION
- All blood from intestines passes straight to liver
- Elimination
- How the drug leaves the body- faecal and urinary routes
- Excretion of waste products
- How the body affects the drug e.g. absorption
- BIOAVAILABILITY
- Amount of drug that reaches the blood stream
- Intravenous= 100%
- Oral Variable 0-100%
- Travel through GI tract
- Most absorbed in SI
- PHARMOCODYNAMICS
- The response of the body to the drug
- How the drug affects the body
- Receptor mediated pharmocodynmics - bind to a cell
Anmerkungen:
- Protein based molecules present on cell membrane.
ACTIVE SITE- LIGAND can bind- once filled with ligand the receptor triggers an effect e.g. opens ion channel.
- Agonist
- Substance mimics ligand, normal response from receptor binding
- Partial Agonist
- substance doesnt fit the active site as well as ligand, elicts partial affects
- DOWNREGULATION of receptors
- Antagonist
- substance reacts with receptor, prevents any response, effectively blocking receptor (INHIBITOR)
- Competitive
- Competes with ligand for active site, drug concentration drops, drug effect wears off, back to normal - REVERSIBLE
- Non Competitive
- Does not compete with ligand, binds at allosteric site- when filled alters shape of the active site, ligand can no longer bind
- Reversible
- COMPETITIVE: effects reversed, drug effect wears off.
- Non Reversible
- may bind to active site or allosteric site, bind permanently- effects are long lasting, no increase in ligand can have an effect.
- UPREGULATION of receptors
- To bind: MUST HAVE AFFINITY
- High Affinity: quick response following administration
- prolonged duration of effect
- drug more competitive
- Low Affinity : higher dose of drug to have an effect
- Non-receptor mediated pharmocodynmics
- Liquid paraffin
- Water
- Laxatives
- Antibiotics
- Antifungals
- Receptors
- Specificity
- A drugs ability to bind to a small number of receptors
- Reduces likelihood of side effects
- Improves safety of drugs
- Makes dose/effect more reliable
- E.G Opiates
- All over the body, morphine causes:
- Vomiting
- Respiratory distress
- Constipation
- Shivering
- Legislation
- Categories of medicines
- POM-V
- Prescription only medicine
- POM-VPS
- Prescription only meds- vet, pharmacist, SQP
- NFA- VPS
- Non-food animal- vet, pharmacist, SQP
- AVM-GSL
- Authorised vet medicine- general sales list